Description
⚠️ FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION
Research Background
PT-141 (Bremelanotide) is a cyclic peptide metabolite of MT-2 and MC3R/MC4R agonist. Research has investigated hypothalamic signalling pathways relevant to reproductive function models.
All research summaries are for informational purposes only and do not constitute medical claims. Vexar Lab compounds are not approved for human use.
Compound Data
- CAS Number: 189691-06-3
- Molecular Formula: C50H68N14O10
- Molecular Weight: 1025.2 g/mol
- Sequence / Structure: Cyclic heptapeptide — metabolite of MT-2
- Appearance: White lyophilised powder
- Solubility: Water soluble
Purity & Testing
- Purity: ≥99% HPLC-UV
- Analysis: HPLC-UV
- Mass Confirmation: ESI-MS
Storage & Handling
- Sealed: −20°C away from light
- Reconstituted: 4°C use within 21 days
- Stability: 24 months
Reconstitution Guide
Reconstitute with bacteriostatic water. Store at 4°C.
For research purposes only — not for human consumption.
Ordering
Minimum order £300. £45 flat worldwide shipping. Custom vial labelling available (+3 weeks lead time). Unlabelled orders dispatch within 1 week.
Legal Disclaimer
FOR RESEARCH USE ONLY. Not for human consumption. Not a medicine. Not intended to diagnose, treat, cure or prevent any disease or medical condition. By purchasing you confirm you are a qualified research professional using this compound for legitimate in-vitro laboratory research purposes only. Vexar Lab accepts no liability for misuse.




Reviews
There are no reviews yet.